New Immunotherapy Prolongs Survival of Lung Cancer Patients

A combination of two immunotherapy drugs has significantly extended survival in patients with one of the deadliest forms of lung cancer, with trial data showing median survival nearly doubling against the current standard of care. Results from the Phase 3 study involving 563 patients were presented during a conference of the European Society for Medical Oncology in Madrid and also published simultaneously in the New England Journal of Medicine.

Immunotherapy is proving to be transformative in cancer treatment, and there is hope that more of these treatments are going to be brought to market by companies like Calidi Biotherapeutics Inc. (NYSE American: CLDI) so that more cancer types can&

Read More>>

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.TinyGems.com

Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: https://www.TinyGems.com/Disclaimer

TinyGems
Austin, Texas
www.TinyGems.com
512.354.7000 Office
[email protected]

TinyGems is powered by IBN

You May Also Be Interested In

• SS Innovations International Inc. (NASDAQ: SSII) Demonstrates Long-Distance Robotic Cardiac Surgery at Industry Events
• Medicilon Presents Revolution Medicines with the "Excellence in Client Partnership Award"
• Hikvision showcases its latest range of AI products and solutions designed to promote growth for SMBs